Tarka and Bladder disorder - a phase IV clinical study of FDA data

Summary:

No or too few reports are found.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

On Sep, 25, 2023

No or too few reports are found.

What is Tarka?

Tarka has active ingredients of trandolapril; verapamil hydrochloride. It is used in high blood pressure. Currently, eHealthMe is studying from 2,383 Tarka users.

What is Bladder Disorder?

Bladder disorder is found to be associated with 1,639 drugs and 870 conditions by eHealthMe. Currently, we are studying 19,158 people who have Bladder disorder.

Do you take Tarka and have Bladder disorder?

Check whether Bladder disorder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Bladder disorder and when was it recovered:

Bladder disorder in Tarka

Expand to all the drugs that have ingredients of trandolapril; verapamil hydrochloride:

Bladder disorder and drugs with ingredients of trandolapril; verapamil hydrochloride

Alternative drugs to, pros and cons of Tarka:

Tarka (2,383 reports)

Browse all side effects of Tarka:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Bladder disorder treatments and more:

Bladder disorder (19,158 reports)

All the drugs that are associated with Bladder disorder:

Bladder disorder

All the conditions that are associated with Bladder disorder:

Bladder disorder

How the study uses the data?

The study uses data from the FDA. It is based on trandolapril; verapamil hydrochloride (the active ingredients of Tarka) and Tarka (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.